Tigilanol tiglate

N/A

Report date: 2024/04/25 17:38:19
NME

Base Information

Drug NameTigilanol tiglate
Drug Alias NameEBC-46
ClassificationSmall moleculesNatural product/Extract
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHead and Neck NeoplasmsMelanomaSarcoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustraliaUnited Kingdom
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesQbiotics
China Registration ClassN/A

Develop Information

Active CompaniesQbiotics
Inactive CompaniesN/A
Active IndicationsHead and Neck NeoplasmsSarcoma
Inactive IndicationsMelanoma

Other Information

ATC CodeN/A
Related LinksN/A